View in EDS

Breast cancer cells survive chemotherapy by activating targetable immune-modulatory programs characterized by PD-L1 or CD80.

Saved in:
Bibliographic Details
Title: Breast cancer cells survive chemotherapy by activating targetable immune-modulatory programs characterized by PD-L1 or CD80.
Authors: Shahbandi A; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, New Orleans, LA, USA., Chiu FY; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, New Orleans, LA, USA., Ungerleider NA; Department of Pathology, Tulane University School of Medicine, New Orleans, LA, USA., Kvadas R; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, New Orleans, LA, USA., Mheidly Z; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, New Orleans, LA, USA., Sun MJS; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, New Orleans, LA, USA., Tian D; Department of Pathology, Tulane University School of Medicine, New Orleans, LA, USA., Waizman DA; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA., Anderson AY; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, New Orleans, LA, USA., Machado HL; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, New Orleans, LA, USA., Pursell ZF; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, New Orleans, LA, USA., Rao SG; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, New Orleans, LA, USA., Jackson JG; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, New Orleans, LA, USA. jjacks8@tulane.edu.
Source: Nature cancer [Nat Cancer] 2022 Dec; Vol. 3 (12), pp. 1513-1533. Date of Electronic Publication: 2022 Dec 08.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36482233
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Breast cancer cells survive chemotherapy by activating targetable immune-modulatory programs characterized by PD-L1 or CD80.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Shahbandi+A%22">Shahbandi A</searchLink>; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, New Orleans, LA, USA.<br /><searchLink fieldCode="AU" term="%22Chiu+FY%22">Chiu FY</searchLink>; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, New Orleans, LA, USA.<br /><searchLink fieldCode="AU" term="%22Ungerleider+NA%22">Ungerleider NA</searchLink>; Department of Pathology, Tulane University School of Medicine, New Orleans, LA, USA.<br /><searchLink fieldCode="AU" term="%22Kvadas+R%22">Kvadas R</searchLink>; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, New Orleans, LA, USA.<br /><searchLink fieldCode="AU" term="%22Mheidly+Z%22">Mheidly Z</searchLink>; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, New Orleans, LA, USA.<br /><searchLink fieldCode="AU" term="%22Sun+MJS%22">Sun MJS</searchLink>; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, New Orleans, LA, USA.<br /><searchLink fieldCode="AU" term="%22Tian+D%22">Tian D</searchLink>; Department of Pathology, Tulane University School of Medicine, New Orleans, LA, USA.<br /><searchLink fieldCode="AU" term="%22Waizman+DA%22">Waizman DA</searchLink>; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Anderson+AY%22">Anderson AY</searchLink>; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, New Orleans, LA, USA.<br /><searchLink fieldCode="AU" term="%22Machado+HL%22">Machado HL</searchLink>; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, New Orleans, LA, USA.<br /><searchLink fieldCode="AU" term="%22Pursell+ZF%22">Pursell ZF</searchLink>; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, New Orleans, LA, USA.<br /><searchLink fieldCode="AU" term="%22Rao+SG%22">Rao SG</searchLink>; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, New Orleans, LA, USA.<br /><searchLink fieldCode="AU" term="%22Jackson+JG%22">Jackson JG</searchLink>; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, New Orleans, LA, USA. jjacks8@tulane.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101761119%22">Nature cancer</searchLink> [Nat Cancer] 2022 Dec; Vol. 3 (12), pp. 1513-1533. <i>Date of Electronic Publication: </i>2022 Dec 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101761119 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2662-1347 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226621347%22">26621347 </searchLink><i>NLM ISO Abbreviation: </i>Nat Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36482233
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s43018-022-00466-y
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1513
    Titles:
      – TitleFull: Breast cancer cells survive chemotherapy by activating targetable immune-modulatory programs characterized by PD-L1 or CD80.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Shahbandi A
      – PersonEntity:
          Name:
            NameFull: Chiu FY
      – PersonEntity:
          Name:
            NameFull: Ungerleider NA
      – PersonEntity:
          Name:
            NameFull: Kvadas R
      – PersonEntity:
          Name:
            NameFull: Mheidly Z
      – PersonEntity:
          Name:
            NameFull: Sun MJS
      – PersonEntity:
          Name:
            NameFull: Tian D
      – PersonEntity:
          Name:
            NameFull: Waizman DA
      – PersonEntity:
          Name:
            NameFull: Anderson AY
      – PersonEntity:
          Name:
            NameFull: Machado HL
      – PersonEntity:
          Name:
            NameFull: Pursell ZF
      – PersonEntity:
          Name:
            NameFull: Rao SG
      – PersonEntity:
          Name:
            NameFull: Jackson JG
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2022 Dec
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2662-1347
          Numbering:
            – Type: volume
              Value: 3
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Nature cancer
              Type: main
ResultId 1